{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:32:55Z","timestamp":1793457175730,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.vaccine.2008.06.008","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T17:41:45Z","timestamp":1221068505000},"page":"L16-L36","source":"Crossref","is-referenced-by-count":96,"special_numbering":"S11","title":["Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean"],"prefix":"10.1016","volume":"26","author":[{"given":"Maribel","family":"Almonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginesa","family":"Albero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Molano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Carcamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 11","key":"10.1016\/j.vaccine.2008.06.008_bib1","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1016\/j.vaccine.2008.05.043","article-title":"Burden and Trends of Type-Specific Human Papillomavirus Infections and Related Diseases in the Latin America and Caribbean Region","volume":"26","author":"Parkin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.06.008_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24S3","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.06.008_bib3","unstructured":"Economic Commission for Latin America and the Caribbean (ECLAC). Statistical Yearbook for Latin America and the Caribbean, 2000. United Nations. 2001."},{"key":"10.1016\/j.vaccine.2008.06.008_bib4","unstructured":"Economic Commission for Latin America and the Caribbean (ECLAC). Statistical Yearbook for Latin America and the Caribbean, 2007. Santiago de Chile: United Nations Publication. 2008."},{"key":"10.1016\/j.vaccine.2008.06.008_bib5","unstructured":"Population Division of the Department of Economic and Social Affairs of the United Nations. World Population Prospects. New York: United Nations, Department of Economic and Social Affairs. 2004 revision available at: http:\/\/www.un.org\/esa\/population\/publications\/WPP2004\/wpp2004.htm 2006 revision available at: http:\/\/www.un.org\/esa\/population\/publications\/wpp2006\/wpp2006.htm (last accessed: April 2008)."},{"key":"10.1016\/j.vaccine.2008.06.008_bib6","series-title":"GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. Version 2. 0","author":"Ferlay","year":"2004"},{"key":"10.1016\/j.vaccine.2008.06.008_bib7","unstructured":"World Health Organization (WHO). World health statistics 2007. Geneva: WHO Press, World Health Organization, 2007."},{"key":"10.1016\/j.vaccine.2008.06.008_bib8","unstructured":"Population Division of the Department of Economic and Social Affairs. World Urbanisation Prospects. New York: United Nations. 2005 revision available at: http:\/\/www.un.org\/esa\/population\/publications\/WUP2005\/2005wup.htm 2007 revision available at: http:\/\/www.un.org\/esa\/population\/unpop.htm (last accessed: April 2008)."},{"key":"10.1016\/j.vaccine.2008.06.008_bib9","unstructured":"Development Data Group of the World Bank's Development Economics Vice Presidency. World Development Indicators (WDI) 2007. The World Bank. Available at: http:\/\/go.worldbank.org\/3JU2HA60D0 (last accessed: April 2008)."},{"key":"10.1016\/j.vaccine.2008.06.008_bib10","unstructured":"EFA Global Monitoring Report. 2006. Education for All-Literacy for Life. Paris: United Nations Educational, Scientific and Cultural Organization (UNESCO), 2005."},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.008_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjose","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.008_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 virus like particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.008_bib13","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste","volume":"191","author":"Herrero","year":"2005","journal-title":"Costa Rica. J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.008_bib14","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ijc.22757","article-title":"Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru","volume":"121","author":"Almonte","year":"2007","journal-title":"Int J Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2008.06.008_bib15","article-title":"HPV and Cervical Cancer in the World, 2007 Report. WHO\/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre).","volume":"25.","author":"Castellsague","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.06.008_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jnci\/92.6.464","article-title":"Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica","volume":"92","author":"Herrero","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.008_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M","article-title":"Epidemiology of HPV infection among Mexican women with normal cervical cytology","volume":"91","author":"Lazcano-Ponce","year":"2001","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.vaccine.2008.06.008_bib18","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1158\/1055-9965.2271.13.12","article-title":"Population-based prevalence and age distribution of human papillomavirus among women in Santiago Chile","volume":"13","author":"Ferreccio","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.008_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.bjc.6600442","article-title":"Prevalence and determinants of HPV infection among Colombian women with normal cytology","volume":"87","author":"Molano","year":"2002","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.vaccine.2008.06.008_bib20","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/ijc.23260","article-title":"Safety, immunogenicity and efficacy of quadrivalent human papillomavirus (types 6,11,16,18) L1 virus-like-particle vaccine in Latin American women","volume":"122","author":"Perez","year":"2008","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.008_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/1055-9965.EPI-06-0670","article-title":"Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18","volume":"16","author":"Xi","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.008_bib22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/89.11.796","article-title":"Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia","volume":"89","author":"Xi","year":"1997","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.008_bib23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3","article-title":"Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities","volume":"69","author":"Londesborough","year":"1996","journal-title":"Int J Cancer"},{"issue":"21","key":"10.1016\/j.vaccine.2008.06.008_bib24","first-page":"7215","article-title":"Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix","volume":"63","author":"Burk","year":"2003","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.008_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/93.4.315","article-title":"Human papillomavirus type 16 variants and risk of cervical cancer","volume":"93","author":"Hildesheim","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"10.1016\/j.vaccine.2008.06.008_bib26","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/jnci\/93.17.1325","article-title":"Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study","volume":"93","author":"Berumen","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.008_bib27","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1086\/507431","article-title":"Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix","volume":"194","author":"Khouadri","year":"2006","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.008_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2003.11.009","article-title":"Genomic diversity of human papillomavirus-16,18,31 and 35 isolates in a Mexican population and relationship to European, African, and Native American variants","volume":"319","author":"Calleja-Macias","year":"2004","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.008_bib29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jmv.10343","article-title":"Human papillomavirus type-16 variants in Quechua aboriginals from Argentina","volume":"69","author":"Picconi","year":"2003","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.008_bib30","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1128\/JVI.71.3.2463-2472.1997","article-title":"Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective","volume":"71","author":"Yamada","year":"1997","journal-title":"J Virol"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2008.06.008_bib31","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1099\/0022-1317-81-12-2959","article-title":"Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia","volume":"81","author":"Villa","year":"2000","journal-title":"J Gen Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.008_bib32","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/ijc.22481","article-title":"High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18","volume":"120","author":"Sichero","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2008.06.008_bib33","unstructured":"Molano M, Huertas A, Hernandez G, Martin C, Mendez F, Murillo R, et al. Presence and persistence of E6\/HPV16 variants in the Colombian cohort. 24th International Papillomavirus Conference and Clinical Workshop. Beijing, November 2007. 7B-07:104."},{"issue":"10","key":"10.1016\/j.vaccine.2008.06.008_bib34","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1128\/JVI.70.10.6987-6993.1996","article-title":"Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation","volume":"70","author":"Stoppler","year":"1996","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.008_bib35","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1128\/JVI.78.11.5934-5945.2004","article-title":"Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras","volume":"78","author":"Chakrabarti","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.008_bib36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.virol.2006.01.038","article-title":"HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6","volume":"350","author":"Lichtig","year":"2006","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.008_bib37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/427825","article-title":"Different P105 promoter activities among natural variants of human papillomavirus type 18","volume":"191","author":"Sichero","year":"2005","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2008.06.008_bib38","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/infdis\/172.6.1584","article-title":"Divergent human papillomavirus type 16 variants are serologically cross-reactive","volume":"172","author":"Cheng","year":"1995","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.008_bib39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/viro.2000.0702","article-title":"NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16","volume":"279","author":"Pastrana","year":"2001","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.008_bib40","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1086\/315451","article-title":"Absence of antibody against human papillomavirus type 16 E6 and E7 in patients with cervical cancer is independent of sequence variations","volume":"181","author":"Nindl","year":"2000","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2008.06.008_bib41","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/425907","article-title":"Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results.","volume":"190","author":"Munoz","year":"2004","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2008.06.008_bib42","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1054\/bjoc.2001.1779","article-title":"HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica","volume":"84","author":"Hildesheim","year":"2001","journal-title":"Br J Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2008.06.008_bib43","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.vaccine.2006.05.031","article-title":"Chapter 6: Epidemiology and transmission dynamics of genital HPV infection","volume":"24","author":"Burchell","year":"2006","journal-title":"Vaccine"},{"issue":"9548","key":"10.1016\/j.vaccine.2008.06.008_bib44","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(06)69479-8","article-title":"Sexual behaviour in context: a global perspective","volume":"368","author":"Wellings","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.06.008_bib45","unstructured":"Population Division of the Department of Economic and Social Affairs. World Marriage Patterns 2000. New York: United Nations. Available at: http:\/\/www.un.org\/esa\/population\/publications\/worldmarriage\/worldmarriage.htm. (last accessed: April 2008)."},{"key":"10.1016\/j.vaccine.2008.06.008_bib46","unstructured":"Population Division of the Department of Economic and Social Affairs. World Contraceptive Use 2005. New York: United Nations. Available at: http:\/\/www.un.org\/esa\/population\/publications\/contraceptive2005\/WCU2005.htm (last accessed: April 2008)."},{"key":"10.1016\/j.vaccine.2008.06.008_bib47","unstructured":"WHO Report on the Global Tobacco Epidemic, 2008 - The MPOWER package. Geneva: World Health Organization, 2008."},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.008_bib48","first-page":"1","article-title":"Global youth tobacco surveillance 2000\u20132007.","volume":"57","author":"Warren","year":"2008","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2008.06.008_bib49","unstructured":"UNAIDS. 2006 report on the global AIDS epidemic. Geneva: United Nations Programme on HIV\/AIDS (UNAIDS), 2006."},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.008_bib50","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1055-9965.EPI-05-0577","article-title":"Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.008_bib51","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.OLQ.0000085181.25063.6C","article-title":"Prevalence of human papillomavirus infection among women in Concordia Argentina: a population-based study","volume":"30","author":"Matos","year":"2003","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.008_bib52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/sti.78.3.204","article-title":"Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women's health clinics in Nicaragua","volume":"78","author":"Claeys","year":"2002","journal-title":"Sex Transm Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.008_bib53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1590\/S1020-49892001000300007","article-title":"Design and results of the USA-Mexico border human papillomavirus (HPV), cervical dysplasia, and Chlamydia trachomatis study","volume":"9","author":"Giuliano","year":"2001","journal-title":"Rev Panam Salud Publica"},{"issue":"22","key":"10.1016\/j.vaccine.2008.06.008_bib54","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM198906013202201","article-title":"Human papillomavirus infection and cervical cancer in Latin America","volume":"320","author":"Reeves","year":"1989","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.008_bib55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ijc.2910440202","article-title":"The male factor in the etiology of cervical cancer among sexually monogamous women","volume":"44","author":"Brinton","year":"1989","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.008_bib56","first-page":"423","article-title":"Risk factors for cervical intraepithelial neoplasia grade III\/carcinoma in situ in Spain and Colombia","volume":"2","author":"Munoz","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"15","key":"10.1016\/j.vaccine.2008.06.008_bib57","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/jnci\/88.15.1068","article-title":"Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease","volume":"88","author":"Munoz","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.008_bib58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1086\/514052","article-title":"Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia","volume":"176","author":"Castellsague","year":"1997","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2008.06.008_bib59","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa011688","article-title":"Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners","volume":"346","author":"Castellsague","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.008_bib60","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/1055-9965.EPI-04-0926","article-title":"Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men","volume":"14","author":"Lajous","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.008_bib61","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/ijc.21992","article-title":"Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico","volume":"119","author":"Vaccarella","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2008.06.008_bib62","doi-asserted-by":"crossref","unstructured":"International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007; 120(4):885-91.","DOI":"10.1002\/ijc.22357"},{"key":"10.1016\/j.vaccine.2008.06.008_bib63","doi-asserted-by":"crossref","unstructured":"International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 2006; 119(5):1108-24.","DOI":"10.1002\/ijc.21953"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.008_bib64","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/1055-9965.EPI-06-0556","article-title":"Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2008.06.008_bib65","doi-asserted-by":"crossref","unstructured":"International Collaboration of Epidemiological Studies of Cervical Cancer., Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, Goodhill A, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007; 370(9599):1609-21.","DOI":"10.1016\/S0140-6736(07)61684-5"},{"issue":"9599","key":"10.1016\/j.vaccine.2008.06.008_bib66","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(07)61667-5","article-title":"Cervical cancer prevention and hormonal contraception","volume":"370","author":"Sasieni","year":"2007","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.vaccine.2008.06.008_bib67","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/94.18.1406","article-title":"A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women","volume":"94","author":"Castle","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.vaccine.2008.06.008_bib68","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1023\/B:CACO.0000003811.98261.3e","article-title":"Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study","volume":"14","author":"Plummer","year":"2003","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.008_bib69","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1054\/bjoc.2000.1523","article-title":"Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort","volume":"83","author":"Deacon","year":"2000","journal-title":"Br J Cancer"},{"issue":"9006","key":"10.1016\/j.vaccine.2008.06.008_bib70","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(96)91417-8","article-title":"Effect of smoking cessation on cervical lesion size","volume":"347","author":"Szarewski","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.06.008_bib71","unstructured":"UNAIDS. AIDS epidemic update: December 2007. Joint United Nations Programme on HIV\/AIDS (UNAIDS) and World Health Organization (WHO), 2007."},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.008_bib72","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4269\/ajtmh.1997.57.138","article-title":"Association of infections with human immunodeficiency virus and human papillomavirus in Honduras","volume":"57","author":"Ferrera","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.06.008_bib73","first-page":"248","article-title":"Prevalence of human papillomavirus and its genotypes in the uterine cervix of HIV-infected and non-infected women","volume":"27","author":"Campos","year":"2005","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.vaccine.2008.06.008_bib74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/oxfordjournals.jncimonographs.a003478","article-title":"Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients--assessing their roles as human papillomavirus cofactors","volume":"31","author":"Castle","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"21","key":"10.1016\/j.vaccine.2008.06.008_bib75","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/jnci\/94.21.1604","article-title":"Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer","volume":"94","author":"Smith","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.008_bib76","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ijc.20257","article-title":"Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study","volume":"111","author":"Smith","year":"2004","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.008_bib77","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4269\/ajtmh.2005.73.1.0730050","article-title":"Chlamydia trachomatis and genital human papillomavirus infections in female university students in Honduras","volume":"73","author":"Tabora","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl. 11","key":"10.1016\/j.vaccine.2008.06.008_bib78","doi-asserted-by":"crossref","first-page":"L37","DOI":"10.1016\/j.vaccine.2008.06.013","article-title":"Cervical Cancer Screening Programs in Latin America and the Caribbean","volume":"26.","author":"Murillo","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl. 11","key":"10.1016\/j.vaccine.2008.06.008_bib79","doi-asserted-by":"crossref","first-page":"L49","DOI":"10.1016\/j.vaccine.2008.05.025","article-title":"New Approaches to Cervical Cancer Screening in Latin America and the Caribbean","volume":"26.","author":"Herrero","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.008_bib80","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1054\/bjoc.2001.1948","article-title":"HPV types and cofactors causing cervical cancer in Peru","volume":"85","author":"Santos","year":"2001","journal-title":"Br J Cancer"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T22:26:48Z","timestamp":1684535208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08007238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":80,"alternative-id":["S0264410X08007238"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.06.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}